27609-91-2

Basic information

• Product Name: Benzonitrile, 4-formyl-3-methyl- (9CI)
• Synonyms: Benzonitrile, 4-formyl-3-methyl- (9CI);4-ForMyl-3-Methylbenzonitrile
• CAS NO: 27609-91-2
• Molecular Formula: C₉H₇NO
• Molecular Weight: 145.15798
• Product Categories: ALDEHYDE
• Mol File: 27609-91-2.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 306.6±30.0 °C(Predicted)
• Appearance: /
• Density: 1.12±0.1 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: Benzonitrile, 4-formyl-3-methyl- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Benzonitrile, 4-formyl-3-methyl- (9CI)(27609-91-2)
• EPA Substance Registry System: Benzonitrile, 4-formyl-3-methyl- (9CI)(27609-91-2)

Safety Data

• Hazardous Substances Data: 27609-91-2(Hazardous Substances Data)

Usage

Uses

4-Formyl-3-methylbenzonitrile is used in preparation of substituted Aryl Methylene type Rubrolide compounds as agrochemical herbicides.

Upstream product

• 24078-12-4 4-bromo-2-methylbenzaldehyde 
• 41963-20-6 4-bromo-3-methylbenzonirtile 
• 68-12-2 N,N-dimethyl-formamide 

Downstream Products

• 959984-46-4 4-(2-acetyl-3-oxobut-1-en-1-yl)-3-methylbenzonitrile 
• 439150-04-6 (2S)-N-tert-Butyl-3-[[(4-cyano-2-methylphenyl)methyl]amino]-2-[[[[3-(trifluoromethyl)benzoyl]amino]acetyl]amino]-propanamide 
• 227094-08-8 (4-cyano-2-methylphenyl)methyl methanesulfonate 
• 401947-09-9 4-(aminomethyl)-3-methylbenzene-1-carboximidamide 
• 227094-09-9 4-(azidomethyl)-3-methylbenzonitrile 
• 227094-07-7 4-hydroxymethyl-3-methylbenzonitrile 
• 198419-90-8 (S)-(+)-α-amino-4-carboxy-2-methylbenzeneacetic acid 
• 198419-90-8 4-((R)-Amino-carboxy-methyl)-3-methyl-benzoic acid 

Relevant articles and documents

QUINUCLIDINES FOR MODULATING ALPHA 7 ACTIVITY

Provided are substituted quinuclidine compounds, pharmaceutical compositions comprising such compounds, and methods of modulating α7 nicotinic acetylcholine receptors and treating neurological disorders using such compounds.

IMIDAZOPYRROLIDINONE COMPOUNDS

The invention relates to compounds of formula (I): (I) as described herein, pharmaceutical preparations comprising such compounds, uses and methods of use for such compounds in the treatment of a disorder or a disease mediated by the activity of MDM2 and/or MDM4, and combinations comprising such compounds.

Phenylglycine derivatives useful for treating disorders of the central nervous system

A pharmaceutical compound of the formula: STR1 in which R1 is hydrogen, hydroxy or C1-6 alkoxy, R2 is hydrogen, carboxy, tetrazolyl, --SO2 H, --SO3 H, --OSO3 H, --CONHOH, or --P(OH)OR', --PO(OH)OR', --OP(OH)OR' or --OPO(OH)OR' where R' is hydrogen, C1-6 alkyl, C2-6 alkenyl or aryl C1-6 alkyl, R3 is hydrogen, hydroxy or C1-4 alkoxy, and R4 is fluoro, trifluoromethyl, nitro, C1-6 alkyl, C3-7 cycloalkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkylthio, heteroaryl, optionally substituted aryl, optionally substituted aryl C1-6 alkyl, optionally substituted aryl C2-6 alkenyl, optionally substituted aryl C2-6 alkynyl, optionally substituted aryloxy, optionally substituted aryl C1-6 alkoxy, optionally substituted arylthio, optionally substituted aryl C1-6 alkylthio or --CONR"R'", --SO2 NR"R"", --NR"R'", --OCONR"R"' or --SONR"R'" where R" and R'" are each hydrogen, C1-6 alkyl or aryl C1-6 alkyl, or R" and R'" together form a C3-7 alkylene ring; provided that (i) R1, R2 and R3 are not all hydrogen,and (ii) when R2 and R3 are hydrogen and R1 is hydroxy, R4 is not fluoro; or a salt or ester thereof.